/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
Company

FDA

Filtered to Regulatory & Policy ×
85 articles decelerating

In 2026, an FDA fast track for digital-health AI and Kintsugi’s clearance failure made the agency a central gatekeeper for healthcare software.

Who they are

FDA appears in this coverage as the U.S. regulator whose clearances, authorizations, trial approvals and enforcement role determine whether consumer devices, clinical software and brain-computer interfaces can move into healthcare use. Its recurring role is especially prominent around Apple, Samsung, Google, Neuralink and smaller digital-health developers.

The recent arc

Coverage intensified in the 2024 wearable-health cycle, led by Samsung’s authorization for Galaxy Watch sleep-apnea detection and the FDA’s approval of Apple’s sleep-apnea detection across recent Apple Watch models. Apple’s AirPods Pro 2 hearing-aid feature then became a landmark story: TechCrunch described it as the first over-the-counter hearing-aid software device.

The tension

The coverage circles a persistent trade-off between accelerating health-tech innovation and preserving a credible clinical gatekeeping function. Apple, Samsung and Google have sought regulatory validation for increasingly medical smartwatch features, while Neuralink and Paradromics depend on authorization to test brain implants; Kintsugi’s shutdown after failing to obtain clearance shows that the same threshold can constrain AI-health startups.

Why it matters

If the fast-track approach to digital health continues, FDA decisions could increasingly shape which AI tools become embedded in healthcare and consumer devices, not merely which conventional medical hardware reaches patients. The unresolved question in the coverage is whether quicker pathways can widen access without weakening the evidentiary standards that distinguish medical claims from general-purpose technology.

FDA has appeared in 85 articles since 2015-03. Coverage peaked in 2024Q2 with 7 articles. Frequently mentioned alongside Apple, the Apple Watch, The Food and Drug Administration, Neuralink.

Articles
85
mentions
Velocity
-25.0%
growth rate
Acceleration
-1.250
velocity change
Sources
34
publications
Robinhood’s $156M Boom Tests Prediction-Market Trust
Robinhood reported $156M in Q2 prediction-market revenue, more than 10 times its year-earlier total and ahead of stocks and crypto, as Kalshi’s disputes exposed...

Coverage Timeline

2026-07-29
New York Times 5 related

Doctors and researchers worry that FDA-related wagers on Kalshi and Polymarket could compromise drug development studies and erode public trust in the process

On the betting websites Kalshi and Polymarket, people can now wager on whether the Food and Drug Administration will decide this year …

2026-06-07
Washington Post 2 related

Inside the Trump admin's push to integrate AI into the healthcare system, including an FDA regulatory fast track for digital health tech like AI chatbots

The administration is laying the groundwork for chatbots that can diagnose illness and prescribe medicine, but physicians say AI can introduce more problems.

2026-06-06
Washington Post 3 related

Inside the Trump admin's push to integrate AI into the healthcare system, including an FDA regulatory fast track for digital health tech like AI chatbots

The administration is laying the groundwork for chatbots that can diagnose illness and prescribe medicine, but physicians say AI can introduce more problems.

2024-06-29
The Verge 25 related

A look at the possible impact of SCOTUS overturning Chevron deference and curbing federal agencies' power on net neutrality, Big Tech regulation, and more

Since the New Deal era, the bulk of the functioning US government is the administrative state — think the acronym soup of agencies like the EPA, FCC, FTC, FDA, and so on.

2024-05-03
MyHealthyApple 10 related

The US FDA approves Apple Watch's AFib history feature for clinical studies, the first digital health tech qualified under the FDA's MDDT program

The FDA today announced that it has qualified the Apple Watch AFib ( Atrial Fibrillation) history feature as an MDDT (Medical Device Development Tools).

2024-02-22
MacRumors 15 related

The US FDA warns the agency has not “authorized, cleared, or approved any smartwatch or smart ring” that claims to measure blood glucose levels non-invasively

As Apple Reportedly Tests Blood Sugar Tech X: @fdadeviceinfo : We issued a safety communication to warn that smartwatches and smart rings claiming to measure blood glucose levels without piercing the ...

2023-03-30
The Record 5 related

The FDA says approval for medical devices now requires meeting certain cybersecurity standards issued in the omnibus spending bill signed in December 2022

The Food and Drug Administration affirmed Wednesday that medical device manufacturers must now prove their products meet certain …

2023-03-02
Reuters 2 related

Sources: the FDA rejected Neuralink's clinical trial application, citing dozens of issues to fix before human testing, like the device's removal and its battery

Musk has said his brain implant company, Neuralink, will make the paralyzed walk, the blind see and eventually turn people into cyborgs.

2022-04-12
Engadget 5 related

Fitbit receives FDA clearance for passive heart rhythm monitoring to detect signs of atrial fibrillation (AFib) and will roll out the feature in the US soon

The Food and Drug Administration has given Fitbit the green light to monitor users' heart rhythms in the background.

2019-06-29
CNBC 7 related

FDA says Medtronic is recalling some insulin pumps that connect wirelessly to other insulin equipment because they can't be updated to address security flaws

Kate Fazzini / CNBC :

Loading articles...

Quarterly Coverage

Top Sources

Narrative

TEXXR tracks 90 tech news articles mentioning FDA, dating back to March 2015. The biggest stories include Neuralink says the company received US FDA approval to launch its first-in-human clinical... and The US FDA clears hypertension notifications on Apple Watch, and Apple plans to roll out.... Frequently covered alongside Apple, The US FDA, the Apple Watch, Neuralink, and The Food and Drug Administration. Coverage has shifted toward safety, research themes and away from consumer, developer.

Key Moments

2024Q2developer -5pts; consumer +25pts; funding +20pts
2024Q3consumer -20pts; funding +20pts
2025Q2developer +13pts; consumer -80pts; funding -23pts

Relationships

Loading graph...